A Phase 1 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04287881 After First Time Administration Of Ascending Single Oral Doses To Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2010
At a glance
- Drugs PF 4287881 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- 29 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2009 Actual initiation date changed from Dec 2008 to Nov 2008 as reported by ClinicalTrials.gov.
- 10 Nov 2009 Planned end date changed from 1 Oct 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.